Ligand validation:7OP9

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OP9_IMD_J_302	96%	72%	0.063	0.973	0.44	0.65	-	-	1	0	100%	1
7OP9_IMD_K_302	94%	73%	0.067	0.966	0.37	0.66	-	-	1	0	100%	1
7OP9_IMD_G_302	94%	69%	0.071	0.968	0.5	0.69	-	-	1	0	100%	1
7OP9_IMD_H_302	90%	70%	0.074	0.958	0.4	0.74	-	-	1	0	100%	1
7OP9_IMD_I_302	90%	71%	0.077	0.961	0.41	0.69	-	-	1	0	100%	1
7OP9_IMD_D_302	89%	72%	0.088	0.966	0.37	0.7	-	-	1	0	100%	1
7OP9_IMD_B_302	88%	70%	0.081	0.956	0.43	0.73	-	-	1	0	100%	1
7OP9_IMD_L_302	86%	71%	0.083	0.952	0.37	0.73	-	-	1	0	100%	1
7OP9_IMD_E_302	84%	72%	0.088	0.951	0.42	0.67	-	-	1	0	100%	1
7OP9_IMD_F_302	84%	70%	0.09	0.953	0.41	0.72	-	-	1	0	100%	1
7OP9_IMD_C_302	84%	70%	0.078	0.938	0.41	0.74	-	-	1	0	100%	1
7OP9_IMD_A_302	80%	70%	0.098	0.947	0.41	0.72	-	-	1	0	100%	1
7OP9_IMD_E_303	71%	74%	0.123	0.944	0.43	0.57	-	-	0	0	100%	1
6G7X_IMD_D_302	86%	73%	0.089	0.957	0.41	0.62	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.